Allspring Global Investments
IONS icon

Allspring Global Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Allspring Global Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-237
Closed -$9.49K – 2080
2024
Q3 		$9.49K Buy
237
+71
+43% +$3.3K ﹤0.01% 2097
2024
Q2 		$7.91K Buy
166
+150
+938% +$6.15K ﹤0.01% 2204
2024
Q1 		$693 Sell
16
-539
-97% -$25.7K ﹤0.01% 2250
2023
Q4 		$28.1K Hold
555
– – ﹤0.01% 1937
2023
Q3 		$25.2K Hold
555
– – ﹤0.01% 2456
2023
Q2 		$22.8K Sell
555
-376,656
-100% -$14.5M ﹤0.01% 2447
2023
Q1 		$13.5M Sell
377,211
-110,852
-23% -$4.16M 0.02% 705
2022
Q4 		$18.4M Buy
488,063
+481,018
+6,828% +$20.2M 0.03% 607
2022
Q3 		$311K Buy
7,045
+1,526
+28% +$64.3K ﹤0.01% 1688
2022
Q2 		$204K Sell
5,519
-81,766
-94% -$3.08M ﹤0.01% 1814
2022
Q1 		$3.23M Sell
87,285
-11,289
-11% -$370K ﹤0.01% 1302
2021
Q4 		$3M Buy
+98,574
New +$3.1M ﹤0.01% 1354

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Allspring Global Investments's IONS Position: Q4 2024 in Review

Allspring Global Investments sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 237 shares — an estimated $9.49K sold.

Allspring Global Investments first reported a position in IONS in Q4 2021 and held it in 12 quarters. The position peaked at $18.4M in Q4 2022. 354 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • Allspring Global Investments reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 237 Ionis Pharmaceuticals shares in Q4 2024, an estimated $9.49K.
  • Allspring Global Investments first reported a position in Ionis Pharmaceuticals in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Ionis Pharmaceuticals position peaked at $18.4M in Q4 2022.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.